Stefan Holdenrieder
- Cancer Research top 0.2%
- Cancer Genomics and Diagnostics 63
- Oncology top 1%
- Pancreatic and Hepatic Oncology Research 28
- Lung Cancer Research Studies 27
- Immunology top 1%
- Molecular Biology top 2%
- Epigenetics and DNA Methylation 23
- RNA modifications and cancer 21
-
- Lung Cancer Treatments and Mutations 23
-
- Neuroendocrine Tumor Research Advances 20
-
- Genetic factors in colorectal cancer 15
- Co-authors
- P StieberDorothea NagelAbel J. BronkhorstVida UngererUğur GezerVolker HeinemannD. SeidelJörg Ellinger
- Cited by
- Cancer ResearchOncologyImmunology
- Journals
- Nature Medicine (1 paper)Journal of Clinical Oncology (4 papers)SHILAP Revista de lepidopterología (5 papers)
- Partner nations
- GermanyUnited StatesTürkiye
In The Last Decade
Stefan Holdenrieder
252 papers receiving 8.5k citations
Hit Papers
Peers
Comparison fields: 5 of 144
- Cancer Research 3.3k
- Oncology 2.4k
- Immunology 1.7k
- Molecular Biology 3.9k
- Pulmonary and Respiratory Medicine 1.6k
Countries citing papers authored by Stefan Holdenrieder
This map shows the geographic impact of Stefan Holdenrieder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Holdenrieder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Holdenrieder more than expected).
Fields of papers citing papers by Stefan Holdenrieder
This network shows the impact of papers produced by Stefan Holdenrieder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Holdenrieder. The network helps show where Stefan Holdenrieder may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Stefan Holdenrieder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 6 | |
| 5 | 2024 | 0 | |
| 6 | 2023 | 3 | |
| 7 | 2023 | 10 | |
| 8 | 2023 | 9 | |
| 9 | 2023 | 19 | |
| 10 | 2023 | 2 | |
| 11 | 2023 | 4 | |
| 12 | 2023 | 10 | |
| 13 | 2022 | 1 | |
| 14 | 2022 | 13 | |
| 15 | 2021 | 2 | |
| 16 | 2021 | 14 | |
| 17 | 2020 | 35 | |
| 18 | 2020 | 1 | |
| 19 | 2019 | 7 | |
| 20 | Relevance of histone marks H3K9me3 and H4K20me3 in cancer. | 2012 | 52 |
About Stefan Holdenrieder
Stefan Holdenrieder is a scholar working on Cancer Research, Oncology and Clinical Biochemistry, having authored 265 papers that have together received 8.7k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (63 papers), Pancreatic and Hepatic Oncology Research (28 papers), Lung Cancer Research Studies (27 papers), Lung Cancer Treatments and Mutations (23 papers), Epigenetics and DNA Methylation (23 papers), RNA modifications and cancer (21 papers), Neuroendocrine Tumor Research Advances (20 papers) and Genetic factors in colorectal cancer (15 papers). The work is most often cited by research in Cancer Research (3.3k citations), Oncology (2.4k citations) and Immunology (1.7k citations). Stefan Holdenrieder has collaborated with scholars based in Germany, United States and Türkiye. Frequent co-authors include P Stieber, Dorothea Nagel, Abel J. Bronkhorst, Vida Ungerer, Uğur Gezer, Volker Heinemann, D. Seidel, Jörg Ellinger, Stefan C. Müller and Stefan Boeck. Their work appears in journals such as Nature Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.